Pediatric Vaccines

In this expert Q and A, James W. Antoon, MD, PhD, MPH, discusses the results of his team's recent study examining the rate of neuropsychiatric events associated with influenza infection and treatment in...

In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...

Tyler Morrissey, MD, discusses the results of his recent study examining the use of general anesthesia as a “teachable moment” for pediatric vaccination against seasonal influenza.

Infectious Diseases Consultant spoke with Emily P. Hyle, MD, whose recent study suggests that new strategies may be needed to improve MMR vaccination rates among US children who travel internationally. ...

Meningococcal B vaccination is recommended for adolescents aged 11 or 12 years. Tamera Coyne-Beasley, MD, MPH, shares her thoughts on the decision-making process for patients and their guardians about...

Infectious Diseases Consultant spoke with George Kassianos, MD, about the extension of the UK’s National Vaccination Programme for influenza among children, and lessons that can be learned by countries...

Dimitri Diavatopoulos, PhD, from the Radboud Center for Infectious Diseases in the Netherlands, answers our questions about controlling pertussis incidence worldwide.